Aeterna Zentaris to Present at Upcoming Canaccord Genuity Global Growth Conference in Boston Français
QUÉBEC CITY, Aug. 7, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the Company's Senior Vice President and CFO, Dennis Turpin, CPA, CA, will be presenting a corporate overview at the Canaccord Genuity 33rd Annual Global Growth Conference on Wednesday, August 14, 2013, at 11:00 am (Eastern), in the Paris Room of the Intercontinental Boston Hotel.
A live audio webcast of this presentation will be available on Aeterna Zentaris' website at www.aezsinc.com in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. For more information, visit www.aezsinc.com.
SOURCE: Aeterna Zentaris Inc.
![](http://rt.newswire.ca/rt.gif?NewsItemId=C4289&Transmission_Id=201308070730CANADANWCANADAPR_C4289&DateId=20130807)
Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
[email protected]
Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
[email protected]
Share this article